Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
BMC Health Services Research
Published in: BMC Health Services Research 1/2018

Open Access 01-12-2018 | Study protocol

Implementing universal Lynch syndrome screening (IMPULSS): protocol for a multi-site study to identify strategies to implement, adapt, and sustain genomic medicine programs in different organizational contexts

Authors: Alanna Kulchak Rahm, Deborah Cragun, Jessica Ezzell Hunter, Mara M. Epstein, Jan Lowery, Christine Y. Lu, Pamala A. Pawloski, Ravi N. Sharaf, Su-Ying Liang, Andrea N. Burnett-Hartman, James M. Gudgeon, Jing Hao, Susan Snyder, Radhika Gogoi, Ilene Ladd, Marc S. Williams

Published in: BMC Health Services Research | Issue 1/2018

Login to get access

Abstract

Background

Systematic screening of all colorectal tumors for Lynch Syndrome (LS) has been recommended since 2009. Currently, implementation of LS screening in healthcare systems remains variable, likely because LS screening involves the complex coordination of multiple departments and individuals across the healthcare system. Our specific aims are to (1) describe variation in LS screening implementation across multiple healthcare systems; (2) identify conditions associated with both practice variation and optimal implementation; (3) determine the relative effectiveness, efficiency, and costs of different LS screening protocols by healthcare system; and (4) develop and test in a real-world setting an organizational toolkit for LS screening program implementation and improvement. This toolkit will promote effective implementation of LS screening in various complex health systems.

Methods

This study includes eight healthcare systems with 22 clinical sites at varied stages of implementing LS screening programs. Guided by the Consolidated Framework for Implementation Research (CFIR), we will conduct in-depth semi-structured interviews with patients and organizational stakeholders and perform economic evaluation of site-specific implementation costs. These processes will result in a comprehensive cross-case analysis of different organizational contexts. We will utilize qualitative data analysis and configurational comparative methodology to identify facilitators and barriers at the organizational level that are minimally sufficient and necessary for optimal LS screening implementation.

Discussion

The overarching goal of this project is to combine our data with theories and tools from implementation science to create an organizational toolkit to facilitate implementation of LS screening in various real-world settings. Our organizational toolkit will account for issues of complex coordination of care involving multiple stakeholders to enhance implementation, sustainability, and ongoing improvement of evidence-based LS screening programs. Successful implementation of such programs will ultimately reduce suffering of patients and their family members from preventable cancers, decrease waste in healthcare system costs, and inform strategies to facilitate the promise of precision medicine.

Trial registration

N/A
Appendix
Available only for authorised users
Literature
1.
Collins FS, Varmus H. A new initiative on precision medicine. N Engl J Med. 2015;372(9):793–5.CrossRef
2.
Palomaki GE, McClain MR, Melillo S, Hampel HL, Thibodeau SN. EGAPP supplementary evidence review: DNA testing strategies aimed at reducing morbidity and mortality from lynch syndrome. Gen Med. 2009;11(1):42–65.
3.
4.
Giardiello FM, Allen JI, Axilbund JE, Boland CR, Burke CA, Burt RW, et al. Guidelines on genetic evaluation and Management of Lynch Syndrome: a consensus statement by the US multi-society task force on colorectal Cancer. Am J Gastroenterol. 2014;109(8):1159–79.CrossRef
5.
Lynch HT, Snyder CL, Shaw TG, Heinen CD, Hitchins MP. Milestones of lynch syndrome: 1895-2015. Nat Rev Cancer. 2015;15(3):181–94.CrossRef
6.
Le DT, Uram JN, Wang H, Bartlett BR, Kemberling H, Eyring AD, et al. PD-1 blockade in tumors with mismatch-repair deficiency. N Engl J Med. 2015;372(26):2509–20.CrossRef
7.
McCann GA, Eisenhauer EL. Hereditary cancer syndromes with high risk of endometrial and ovarian cancer: surgical options for personalized care. J Surg Oncol 2015;111(1):118–124.CrossRef
8.
Hampel H, de la Chapelle A. The search for unaffected individuals with lynch syndrome: do the ends justify the means? Cancer Prev Res. 2011;4(1):1–5.CrossRef
9.
Cancer Moonshot Blue Ribbon Panel Report 2016. National Cancer Institute: 2016 10/17/2016. Report No.
10.
Stoffel EM, Mangu PB, Gruber SB, Hamilton SR, Kalady MF, Lau MW, et al. Hereditary colorectal cancer syndromes: American Society of Clinical Oncology clinical practice guideline endorsement of the familial risk-colorectal cancer: European Society for Medical Oncology clinical practice guidelines. J Clin Oncol. 2015;33(2):209–17.CrossRef
11.
12.
Balmana J, Balaguer F, Cervantes A, Arnold D. Familial risk-colorectal cancer: ESMO Clinical Practice Guidelines. Ann Oncol. 2013;24(Suppl 6):vi73–80.CrossRef
13.
Syngal S, Brand RE, Church JM, Giardiello FM, Hampel HL, Burt RW. ACG clinical guideline: genetic testing and management of hereditary gastrointestinal cancer syndromes. Am J Gastroenterol. 2015;110(2):223–62 quiz 63.CrossRef
14.
Weissman SM, Burt R, Church J, Erdman S, Hampel H, Holter S, et al. Identification of individuals at risk for lynch syndrome using targeted evaluations and genetic testing: National Society of genetic counselors and the collaborative Group of the Americas on inherited colorectal Cancer joint practice guideline. J Genet Couns. 2012;21(4):484–93.CrossRef
15.
Network NCC. NCCN Clinical Practice Guidelines in Oncology: Genetic/Familial High-Risk Assessment: Colorectal 2016 [updated 9/26/20165/1/2017]. Available from: nccn.​org.
16.
Rubenstein JH, Enns R, Heidelbaugh J, Barkun A. American Gastroenterological Association Institute Guideline on the Diagnosis and Management of Lynch Syndrome. Gastroenterology. 2015;149(3):777–82 quiz e16–7.CrossRef
17.
Khoury MJ, Coates RJ, Fennell ML, Glasgow RE, Scheuner MT, Schully SD, et al. Multilevel research and the challenges of implementing genomic medicine. J Natl Cancer Inst Monogr. 2012;2012(44):112–20.CrossRef
18.
Bellcross CA, Bedrosian SR, Daniels E, Duquette D, Hampel H, Jasperson K, et al. Implementing screening for lynch syndrome among patients with newly diagnosed colorectal cancer: summary of a public health/clinical collaborative meeting. Gen Med. 2012;14(1):152–62.
19.
Cragun D, DeBate RD, Vadaparampil ST, Baldwin J, Hampel H, Pal T. Comparing universal lynch syndrome tumor-screening programs to evaluate associations between implementation strategies and patient follow-through. Gen Med. 2014;16(10):773–82.
20.
Ladabaum U, Wang G, Terdiman J, Blanco A, Kuppermann M, Boland CR, et al. Strategies to identify the lynch syndrome among patients with colorectal cancer: a cost-effectiveness analysis. Ann Intern Med. 2011;155(2):69–79.CrossRef
21.
Mvundura M, Grosse SD, Hampel H, Palomaki GE. The cost-effectiveness of genetic testing strategies for lynch syndrome among newly diagnosed patients with colorectal cancer. Gen Med. 2010;12(2):93–104.
22.
Khoury MJ, Feero WG, Valdez R. Family history and personal genomics as tools for improving health in an era of evidence-based medicine. Am J Prev Med. 2010;39(2):184–8.CrossRef
23.
Recommendations from the EGAPP Working Group. Genetic testing strategies in newly diagnosed individuals with colorectal cancer aimed at reducing morbidity and mortality from Lynch syndrome in relatives. Gen Med. 2009;11(1):35–41.
24.
Wade JE, Ledbetter DH, Williams MS. Implementation of genomic medicine in a health care delivery system: a value proposition? American journal of medical genetics part C. Sem Med Gen. 2014;166c(1):112–6.
25.
Williams MS. Perspectives on what is needed to implement genomic medicine. Mol Gen Genom Med. 2015;3(3):155–9.CrossRef
26.
Mittman B. Implementation science in health care. In: Brownson RCCG, Proctor EK, editors. Dissemination and implementation research in health. New York: Oxford University Press; 2012. p. 400–18.
27.
Snyder SR, Mitropoulou C, Patrinos GP, Williams MS. Economic evaluation of pharmacogenomics: a value-based approach to pragmatic decision making in the face of complexity. Public Health Genom. 2014;17(5–6):256–64.CrossRef
28.
Williams M. Delivery of personalized medicine in an integrated healthcare system. In: Ginsburg GS, Willard HF, editors. Genomic and personalized medicine. 2nd ed. New York: Elsevier Inc; 2013. p. 340–52.CrossRef
29.
Gudgeon JM, Belnap TW, Williams JL, Williams MS. Impact of age cutoffs on a lynch syndrome screening program. J Oncol Pract. 2013;9(4):175–9.CrossRef
30.
Gudgeon JM, Williams JL, Burt RW, Samowitz WS, Snow GL, Williams MS. Lynch syndrome screening implementation: business analysis by a healthcare system. Am J Manag Care. 2011;17(8):e288–300.PubMed
31.
Heald B, Plesec T, Liu X, Pai R, Patil D, Moline J, et al. Implementation of universal microsatellite instability and immunohistochemistry screening for diagnosing lynch syndrome in a large Academic Medical Center. J Clin Oncol. 2013;31(10):1336–40.CrossRef
32.
Cross DS, Rahm AK, Kauffman TL, Webster J, Le AQ, Spencer Feigelson H, et al. Underutilization of lynch syndrome screening in a multisite study of patients with colorectal cancer. Gen Med. 2013;15(12):933–40.
33.
Corinne Daly CR, Facey M, Baker NA, Baxter NN. Reflex lynch syndrome screening by example: a review of existing programs. J Clin Oncol. 2015;33((suppl 3)) abstr 543.CrossRef
34.
Cohen SA. Current lynch syndrome tumor screening practices: a survey of genetic counselors. J Genet Couns. 2014;23(1):38–47.CrossRef
35.
Beamer LC, Grant ML, Espenschied CR, Blazer KR, Hampel HL, Weitzel JN, et al. Reflex immunohistochemistry and microsatellite instability testing of colorectal tumors for lynch syndrome among US cancer programs and follow-up of abnormal results. J Clin Oncol. 2012;30(10):1058–63.CrossRef
36.
Damschroder LJ, Aron DC, Keith RE, Kirsh SR, Alexander JA, Lowery JC. Fostering implementation of health services research findings into practice: a consolidated framework for advancing implementation science. Implement Sci. 2009;4:50.CrossRef
37.
Damschroder LJ, Lowery JC. Evaluation of a large-scale weight management program using the consolidated framework for implementation research (CFIR). Implement Sci. 2013;8:51.CrossRef
38.
Cragun D, Pal T, Vadaparampil ST, Baldwin J, Hampel H, DeBate RD. Qualitative comparative analysis: a hybrid method for identifying factors associated with program effectiveness. J Mixed Methods Res. 2015;10(3):251–72.CrossRef
39.
Thiem A. Conducting configurational comparative research with qualitative comparative analysis: a hands-on tutorial for applied evaluation scholars and practitioners. Am J Eval. 2017;38(3):420–33.CrossRef
40.
Rahm AK, Boggs JM, Martin C, Price DW, Beck A, Backer TE, et al. Facilitators and barriers to implementing SBIRT in primary Care in Integrated Health Care Settings. Subst Abus. 2014:0.
41.
Schneider JL, Davis J, Kauffman TL, Reiss JA, McGinley C, Arnold K, et al. Stakeholder perspectives on implementing a universal lynch syndrome screening program: a qualitative study of early barriers and facilitators. Gen Med. 2015.
42.
Harris JN, Liljestrand P, Alexander GL, Goddard KA, Kauffman T, Kolevska T, et al. Oncologists' attitudes toward KRAS testing: a multisite study. Cancer Med. 2013;2(6):881–8.CrossRef
43.
Hamilton AB, Oishi S, Yano EM, Gammage CE, Marshall NJ, Scheuner MT. Factors influencing organizational adoption and implementation of clinical genetic services. Gen Med. 2014;16(3):238–45.
44.
Hunter JE, Zepp JM, Gilmore MJ, Davis JV, Esterberg EJ, Muessig KR, et al. Universal tumor screening for lynch syndrome: Assessment of the perspectives of patients with colorectal cancer regarding benefits and barriers. Cancer. 2015:n/a-n/a.
45.
Beebe J. Rapid assessment process: an introduction. Walnut Creek: AltaMira Press; 2001.
46.
Padgett DK. Qualitative and mixed methods in public health. Thousand Oaks, CA: Sage; 2012.CrossRef
47.
48.
49.
Berg-Schlosser DDM, Rihoux G, Ragin B, Charles C. Qualitative comparative analysis (QCA) as an approach. In: BRCC R, editor. Configurational comparative methods: qualitative comparative analysis (QCA) and related techniques. Thousand Oaks: Sage Publications, Inc; 2009.
50.
Kahwati LC, Lewis MA, Kane H, Williams PA, Nerz P, Jones KR, et al. Best practices in the veterans health Administration's MOVE! Weight management program. Am J Prev Med. 2011;41(5):457–64.CrossRef
51.
Baumgartner M. Detecting causal chains in small-n data. Field Methods. 2012;25(1):3–24.CrossRef
52.
Basurto X, Speer J. Structuring the calibration of qualitative data as sets for qualitative comparative analysis (QCA). Field Methods. 2012;24(2):155–74.CrossRef
53.
Schneider C, Wagemann C. Standards of Good Practice in Qualitative Comparative Analysis (QCA) and Fuzzy-Sets 2010. 397–418 p.CrossRef
54.
Legewie N. Anchored Calibration: From Qualitative Data to Fuzzy Sets. 2017. 2017;18(3).
55.
Baumgartner M, Thiem A. Identifying Complex Causal Dependencies in Configurational Data with Coincidence Analysis 2015. 176–84 p.
56.
Grosse SD, Palomaki GE, Mvundura M, Hampel H. The cost-effectiveness of routine testing for lynch syndrome in newly diagnosed patients with colorectal cancer in the United States: corrected estimates. Gen Med. 2015;17(6):510–1.
57.
Rahm A, Hawkins R, Dearing J, Pingree S, Lomax J, McDowell H, et al. Implementing an evidence-based breast cancer support and communication tool to newly diagnosed patients as standard care in two institutions. Translat Behav Med. 2015;5(2):198–206.CrossRef
58.
National Academies of Sciences E, and Medicine. Applying an implementation science approach to genomic medicine: Workshop Summary. Washington, DC: The National Academies Press; 2016.
59.
Sculpher MJ, Pang FS, Manca A, Drummond MF, Golder S, Urdahl H, et al. Generalisability in economic evaluation studies in healthcare: a review and case studies. Health Technol Assess. 2004;8(49):iii–v 1–192.CrossRef
60.
Schlander M. The use of cost-effectiveness by the National Institute for health and clinical excellence (NICE): no(t yet an) exemplar of a deliberative process. J Med Ethics. 2008;34(7):534–9.CrossRef
61.
Hampel H, Pearlman R, Beightol M, et al. Assessment of tumor sequencing as a replacement for lynch syndrome screening and current molecular tests for patients with colorectal cancer. JAMA Oncol. 2018.
Metadata
Title
Implementing universal Lynch syndrome screening (IMPULSS): protocol for a multi-site study to identify strategies to implement, adapt, and sustain genomic medicine programs in different organizational contexts
Authors
Alanna Kulchak Rahm
Deborah Cragun
Jessica Ezzell Hunter
Mara M. Epstein
Jan Lowery
Christine Y. Lu
Pamala A. Pawloski
Ravi N. Sharaf
Su-Ying Liang
Andrea N. Burnett-Hartman
James M. Gudgeon
Jing Hao
Susan Snyder
Radhika Gogoi
Ilene Ladd
Marc S. Williams
Publication date
01-12-2018
Publisher
BioMed Central
Published in
BMC Health Services Research / Issue 1/2018
Electronic ISSN: 1472-6963
DOI
https://doi.org/10.1186/s12913-018-3636-2

Other articles of this Issue 1/2018

BMC Health Services Research 1/2018 Go to the issue

Research article

Physicians’ knowledge, attitudes, and perceptions concerning antibiotic resistance: a survey in a Ghanaian tertiary care hospital

Research article

Qualitative assessment of the primary care outcomes questionnaire: a cognitive interview study

Research article

Physiotherapists’ views of implementing a stratified treatment approach for patients with low back pain in Germany: a qualitative study

Research article

Trends in healthcare utilization and costs associated with acute otitis media in the United States during 2008–2014

Debate

Sustainability in Health care by Allocating Resources Effectively (SHARE) 11: reporting outcomes of an evidence-driven approach to disinvestment in a local healthcare setting

Research article

Availability of post-hospital services supporting community reintegration for children with identified surgical need in Uganda